| Opaleye Management Inc. |
Non-Executive |
SANUWAVE Health, Inc. (SNWVD)
|
2024-11-01 |
$15.75 |
0.0% |
27,868
|
$438,902 |
| Opaleye Management Inc. |
Non-Executive |
CODEXIS, INC. (CDXS)
|
2024-10-25 |
$2.91 |
0.0% |
25,000
|
$72,720 |
| Opaleye Management Inc. |
Non-Executive |
Eton Pharmaceuticals, Inc. (ETON)
|
2024-10-23 |
$7.98 |
0.0% |
10,000
|
$79,814 |
| Opaleye Management Inc. |
Non-Executive |
Eton Pharmaceuticals, Inc. (ETON)
|
2024-10-08 |
$6.99 |
0.0% |
62,070
|
$434,137 |
| Opaleye Management Inc. |
Non-Executive |
CODEXIS, INC. (CDXS)
|
2024-09-25 |
$2.93 |
0.0% |
85,000
|
$249,147 |
| Opaleye Management Inc. |
Non-Executive |
CODEXIS, INC. (CDXS)
|
2024-09-23 |
$3.01 |
0.0% |
1,100,000
|
$3,308,034 |
| Opaleye Management Inc. |
Non-Executive |
CODEXIS, INC. (CDXS)
|
2024-09-18 |
$3.16 |
0.0% |
61,000
|
$192,992 |
| Opaleye Management Inc. |
Non-Executive |
Eton Pharmaceuticals, Inc. (ETON)
|
2024-09-11 |
$4.70 |
0.0% |
107,500
|
$504,875 |
| Opaleye Management Inc. |
Non-Executive |
HARROW, INC. (HROW)
|
2024-04-25 |
$9.97 |
301.6% |
20,000
|
$199,400 |
| Opaleye Management Inc. |
Non-Executive |
HARROW, INC. (HROW)
|
2024-04-24 |
$10.23 |
291.3% |
20,000
|
$204,640 |
| Opaleye Management Inc. |
Non-Executive |
HARROW, INC. (HROW)
|
2024-04-19 |
$10.56 |
279.3% |
29,400
|
$310,390 |
| Opaleye Management Inc. |
Non-Executive |
HARROW, INC. (HROW)
|
2024-03-28 |
$12.82 |
212.3% |
50,000
|
$641,000 |
| Opaleye Management Inc. |
Non-Executive |
HARROW, INC. (HROW)
|
2024-03-20 |
$9.65 |
314.9% |
50,600
|
$488,290 |
| Opaleye Management Inc. |
Non-Executive |
HARROW, INC. (HROW)
|
2023-11-15 |
$8.03 |
398.7% |
25,000
|
$200,735 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2023-09-20 |
$14.60 |
174.2% |
20,000
|
$292,076 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2023-03-09 |
$27.60 |
-99.8% |
8,725
|
$240,821 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2022-12-14 |
$10.52 |
280.6% |
431,183
|
$4,536,045 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-12-14 |
$25.06 |
-99.7% |
8,375
|
$209,876 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-11-03 |
$7.81 |
-64.4% |
20,262
|
$158,285 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-10-18 |
$33.00 |
-99.8% |
625
|
$20,625 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-10-11 |
$8.00 |
-65.3% |
16,000
|
$128,000 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-09-29 |
$34.83 |
-99.8% |
470
|
$16,370 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2022-09-28 |
$9.77 |
309.6% |
11,085
|
$108,354 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-09-27 |
$33.85 |
-99.8% |
85
|
$2,877 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-09-22 |
$34.59 |
-99.8% |
866
|
$29,943 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-09-20 |
$37.05 |
-99.8% |
500
|
$18,524 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-09-19 |
$8.09 |
-65.6% |
18,000
|
$145,584 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-09-19 |
$37.47 |
-99.8% |
250
|
$9,366 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-09-16 |
$8.09 |
-65.7% |
6,530
|
$52,853 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2022-09-15 |
$3.93 |
-51.6% |
23,900
|
$93,808 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-08-16 |
$8.00 |
-65.3% |
315,000
|
$2,520,000 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-08-16 |
$8.10 |
-65.7% |
5,221
|
$42,285 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-08-10 |
$8.52 |
-67.4% |
11,979
|
$102,089 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-08-01 |
$7.96 |
-65.1% |
4,979
|
$39,632 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-07-26 |
$34.40 |
-99.8% |
113
|
$3,877 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-07-22 |
$8.02 |
-65.3% |
5,200
|
$41,709 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-07-21 |
$8.03 |
-65.4% |
10,333
|
$83,010 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-07-20 |
$8.08 |
-65.6% |
5,100
|
$41,192 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-07-15 |
$35.63 |
-99.8% |
591
|
$21,068 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-07-14 |
$36.24 |
-99.8% |
359
|
$13,024 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-07-01 |
$7.00 |
-60.3% |
200
|
$1,400 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-06-30 |
$7.00 |
-60.3% |
3,567
|
$24,969 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-06-24 |
$27.84 |
-99.8% |
571
|
$15,894 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-06-22 |
$6.99 |
-60.2% |
2,400
|
$16,776 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-06-21 |
$26.25 |
-99.7% |
42,099
|
$1,105,279 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-06-10 |
$6.50 |
-57.2% |
52,400
|
$340,574 |
| Opaleye Management Inc. |
Non-Executive |
TELA Bio, Inc. (TELA)
|
2022-06-10 |
$5.60 |
-50.4% |
27,500
|
$154,066 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-05-10 |
$35.12 |
-99.8% |
485
|
$17,032 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-04-25 |
$44.50 |
-99.8% |
2,639
|
$117,438 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-04-22 |
$39.60 |
-99.8% |
355
|
$14,058 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-04-14 |
$49.99 |
-99.9% |
1,002
|
$50,091 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2022-04-13 |
$6.75 |
492.9% |
41,389
|
$279,502 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-04-12 |
$49.16 |
-99.9% |
1,360
|
$66,846 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2022-04-08 |
$4.78 |
-60.3% |
10,136
|
$48,487 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-03-16 |
$44.00 |
-99.8% |
112
|
$4,917 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-01-28 |
$44.00 |
-99.8% |
25
|
$1,100 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2022-01-28 |
$6.89 |
481.4% |
6,343
|
$43,686 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2022-01-28 |
$4.96 |
-61.7% |
24,031
|
$119,271 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-01-24 |
$42.94 |
-99.8% |
2,618
|
$112,414 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2022-01-20 |
$44.90 |
-99.9% |
2,250
|
$101,032 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2021-12-29 |
$50.21 |
-99.9% |
2,616
|
$131,362 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2021-12-29 |
$6.60 |
-71.2% |
11,591
|
$76,498 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2021-12-28 |
$57.34 |
-99.9% |
5,373
|
$308,052 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2021-12-27 |
$6.53 |
-70.9% |
38,000
|
$248,293 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2021-12-20 |
$6.49 |
-70.7% |
703
|
$4,562 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2021-12-17 |
$6.46 |
-70.6% |
10,353
|
$66,899 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2021-12-15 |
$48.52 |
-99.9% |
1,098
|
$53,287 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2021-12-14 |
$51.22 |
-99.9% |
2,860
|
$146,498 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2021-12-06 |
$45.78 |
-99.9% |
5,600
|
$256,385 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2021-12-02 |
$47.87 |
-99.9% |
3,025
|
$144,820 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2021-11-18 |
$6.98 |
-72.8% |
24,324
|
$169,774 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2021-11-04 |
$6.50 |
-70.8% |
6,557
|
$42,620 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2021-08-19 |
$8.45 |
374.1% |
52,500
|
$443,362 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2021-08-18 |
$8.62 |
364.7% |
72,500
|
$624,697 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2021-07-21 |
$7.31 |
447.4% |
20,000
|
$146,290 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2021-06-18 |
$8.34 |
379.8% |
74,584
|
$622,389 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2020-12-22 |
$5.26 |
661.6% |
106,416
|
$559,482 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2020-12-22 |
$161.20 |
-100.0% |
24,814
|
$3,999,993 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2020-10-21 |
$87.94 |
-99.9% |
433
|
$38,060 |
| Opaleye Management Inc. |
Non-Executive |
Eton Pharmaceuticals, Inc. (ETON)
|
2020-10-16 |
$7.00 |
-34.1% |
400,000
|
$2,800,000 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2020-09-30 |
$16.00 |
-88.1% |
50,000
|
$800,000 |
| Opaleye Management Inc. |
Non-Executive |
Protara Therapeutics, Inc. (TARA)
|
2020-09-24 |
$16.87 |
-88.7% |
300,000
|
$5,061,000 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2020-09-24 |
$94.52 |
-99.9% |
3,937
|
$372,095 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2020-09-09 |
$67.51 |
-99.9% |
2,828
|
$190,902 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2020-09-02 |
$45.54 |
-99.9% |
7,990
|
$363,825 |
| Opaleye Management Inc. |
Non-Executive |
Tracon Pharmaceuticals, Inc. (TCON)
|
2020-08-31 |
$34.84 |
-99.8% |
27,275
|
$950,378 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2020-07-12 |
$4.97 |
705.6% |
112,700
|
$560,133 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2020-07-09 |
$5.02 |
698.2% |
136,300
|
$683,704 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2020-06-19 |
$5.58 |
617.2% |
35,000
|
$195,402 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2020-06-04 |
$5.73 |
598.8% |
50,000
|
$286,508 |
| Opaleye Management Inc. |
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2020-05-22 |
$4.85 |
725.2% |
25,900
|
$125,666 |
| Opaleye Management Inc. |
Non-Executive |
OCULAR THERAPEUTIX, INC (OCUL)
|
2020-01-02 |
$3.90 |
116.4% |
15,000
|
$58,508 |
| Opaleye Management Inc. |
Non-Executive |
OCULAR THERAPEUTIX, INC (OCUL)
|
2019-12-30 |
$3.97 |
112.6% |
20,000
|
$79,410 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
65.6% |
$25,932,693 |
$39,542,057 |